(PDF) Pss46 - Differences in Hta Coverage Recommendations:

Pss46 - Differences in Hta Coverage Recommendations: Comparing Ophthalmology Drug Reimbursement Decisions in Four European Countries

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.2546

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

The Reimbursement of Expensive Drugs in Hospitals in Western European Countries

Value in Health

Occupational Health

English

Php223 - Trerapeutic Areas, a Key Factor for Hta and Reimbursement Decisions, Timming and Access

Value in Health

Occupational Health

English

Reimbursement Measures in European Countries – Findings of a Bibliometric Literature Review

Journal of Pharmaceutical Policy and Practice

English

Php63 What Influences Pharmaceutical Reimbursement Decisions? A Systematic Review of Factors Reported to Influence Decisions in Oecd Countries

Value in Health

Occupational Health

English

Psy184 - Hta and Reimbursement Considerations for Rare Diseases in European Markets: What Are the Implications for Manufacturers?s?

Value in Health

Occupational Health

English

Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences With Other European Countries

Multidisciplinary

English

Reimbursement Decision Landscape for Orphan Drugs Across Six Hta Agencies

Value in Health

Occupational Health

English

Reimbursement Decisions in Oncology Drugs: An International Analysis

Value in Health

Occupational Health

English

Pmd157 - Assessment of in Vitro Diagnostic Reimbursement Practices in European Countries: Identified Hurdles and Possible Solutions.

Value in Health

Occupational Health

English